Large-scale testing (Phase 3)Study completedNCT00690612
What this trial is testing
Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)
Who this might be right for
Hypertension
AstraZeneca 35